The development of type 2 diabetes is caused by a combination of lifestyle and genetic factors.[24][26] While some of these factors are under personal control, such as diet and obesity, other factors are not, such as increasing age, female gender, and genetics.[10] A lack of sleep has been linked to type 2 diabetes.[27] This is believed to act through its effect on metabolism.[27] The nutritional status of a mother during fetal development may also play a role, with one proposed mechanism being that of DNA methylation.[28] The intestinal bacteria Prevotella copri and Bacteroides vulgatus have been connected with type 2 diabetes.[29]
Get Educated: The American Diabetes Association advises that all persons with diabetes receive diabetes self-management education (DSME) at diagnosis and thereafter. A certified diabetes educator or other qualified health professional can give you the tools you need to understand and take care of your diabetes. In addition, these individuals are trained to create a customized plan that works for you. Diabetes self-management education is a patient-centered approach that enables patients to get involved in their care.
Every cell in the human body needs energy in order to function. The body's primary energy source is glucose, a simple sugar resulting from the digestion of foods containing carbohydrates (sugars and starches). Glucose from the digested food circulates in the blood as a ready energy source for any cells that need it. Insulin is a hormone or chemical produced by cells in the pancreas, an organ located behind the stomach. Insulin bonds to a receptor site on the outside of cell and acts like a key to open a doorway into the cell through which glucose can enter. Some of the glucose can be converted to concentrated energy sources like glycogen or fatty acids and saved for later use. When there is not enough insulin produced or when the doorway no longer recognizes the insulin key, glucose stays in the blood rather entering the cells.
There are other factors that also fall into the category of environmental (as opposed to genetic) causes of diabetes. Certain injuries to the pancreas, from physical trauma or from drugs, can harm beta cells, leading to diabetes. Studies have also found that people who live in polluted areas are prone to type 2, perhaps because of inflammation. And an alternate theory of insulin resistance places the blame on damage caused by inflammation. Age also factors into type 2; beta cells can wear out over time and become less capable of producing enough insulin to overcome insulin resistance, which is why older people are at greater risk of type 2.
While discovering you have diabetes can be a terrifying prospect, the sooner you’re treated, the more manageable your condition will be. In fact, a review of research published in the American Diabetes Association journal Diabetes Care reveals that early treatment with insulin can help patients with type 2 diabetes manage their blood sugar better and gain less weight than those who start treatment later.

Examples of simple or refined carbohydrates, on the other hand, exist in various forms — from the sucrose in the table sugar you use to bake cookies, to the various kinds of added sugar in packaged snacks, fruit drinks, soda, and cereal. Simple carbohydrates are natural components of many fresh foods, too, such as the lactose in milk and the fructose in fruits, and therefore, a healthy, well-balanced diet will always contain these types of sugars.
Although many of the symptoms of type 1 and type 2 diabetes are similar, they present in very different ways. Many people with type 2 diabetes won’t have symptoms for many years. Then often the symptoms of type 2 diabetes develop slowly over the course of time. Some people with type 2 diabetes have no symptoms at all and don’t discover their condition until complications develop.

Doctors and people with diabetes have observed that infections seem more common if you have diabetes. Research in this area, however, has not proved whether this is entirely true, nor why. It may be that high levels of blood sugar impair your body's natural healing process and your ability to fight infections. For women, bladder and vaginal infections are especially common.
Type 2 diabetes (formerly named non-insulin-dependent) which results from the body's inability to respond properly to the action of insulin produced by the pancreas. Type 2 diabetes is much more common and accounts for around 90% of all diabetes cases worldwide. It occurs most frequently in adults, but is being noted increasingly in adolescents as well.
Per the WHO, people with fasting glucose levels from 6.1 to 6.9 mmol/l (110 to 125 mg/dl) are considered to have impaired fasting glucose.[67] people with plasma glucose at or above 7.8 mmol/l (140 mg/dl), but not over 11.1 mmol/l (200 mg/dl), two hours after a 75 gram oral glucose load are considered to have impaired glucose tolerance. Of these two prediabetic states, the latter in particular is a major risk factor for progression to full-blown diabetes mellitus, as well as cardiovascular disease.[68] The American Diabetes Association (ADA) since 2003 uses a slightly different range for impaired fasting glucose of 5.6 to 6.9 mmol/l (100 to 125 mg/dl).[69]

Random blood sugar test. A blood sample will be taken at a random time. Blood sugar values are expressed in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L). Regardless of when you last ate, a random blood sugar level of 200 mg/dL (11.1 mmol/L) or higher suggests diabetes, especially when coupled with any of the signs and symptoms of diabetes, such as frequent urination and extreme thirst.
Diabetes mellitus is a diagnostic term for a group of disorders characterized by abnormal glucose homeostasis resulting in elevated blood sugar. There is variability in its manifestations, wherein some individuals have only asymptomatic glucose intolerance, while others present acutely with diabetic ketoacidosis, and still others develop chronic complications such as nephropathy, neuropathy, retinopathy, or accelerated atherosclerosis. It is among the most common of chronic disorders, affecting up to 5–10% of the adult population of the Western world. Its prevalence varies over the globe, with certain populations, including some American Indian tribes and the inhabitants of Micronesia and Polynesia, having extremely high rates of diabetes (1,2). The prevalence of diabetes is increasing dramatically and it has been estimated that the worldwide prevalence will increase by more than 50% between the years 2000 and 2030 (3).
FIGURE 19-1 ■. This figure shows the hyperbolic relationship of insulin resistance and beta cell function. On the y-axis is beta cell function as reflected in the first-phase insulin response during intravenous (IV) glucose infusion; on the x-axis is insulin sensitivity and its mirror image resistance. In a subject with normal glucose tolerance (NGT) and beta-cell reserve, an increase in insulin resistance results in increased insulin release and normal glucose tolerance. In an individual for whom the capacity to increase insulin release is compromised, increasing insulin resistance with partial or no beta-cell compensation results in progression from normal glucose tolerance, to impaired glucose tolerance (IGT), and finally to diabetes (T2D). Differences between these categories are small at high insulin sensitivity, which may be maintained by weight reduction, exercise, and certain drugs. At a critical degree of insulin resistance, due to obesity or other listed factors, only a further small increment in resistance requires a large increase in insulin output. Those that can increase insulin secretion to this extent retain normal glucose tolerance; those who cannot achieve this degree of insulin secretion (e.g., due to a mild defect in genes regulating insulin synthesis, insulin secretion, insulin action, or an ongoing immune destruction of beta cells) now unmask varying degrees of carbohydrate intolerance. The product of insulin sensitivity (the reciprocal of insulin resistance) and acute insulin response (a measurement beta-cell function) has been called the “disposition index.” This index remains constant in an individual with normal beta cell compensation in response to changes in insulin resistance. IGT, impaired glucose tolerance; NGT, normal glucose tolerance; T2D, type 2 diabetes.
^ Jump up to: a b Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ (September 2009). "The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation". Health Technology Assessment. 13 (41): 1–190, 215–357, iii–iv. doi:10.3310/hta13410. PMID 19726018.

Acute Coronary Syndrome Moderate Risk Acute Coronary Syndrome Management Low Risk Acute Coronary Syndrome Management Myocardial Infarction Stabilization Post Myocardial Infarction Medications Cardiac Rehabilitation Angina Pectoris Heart Failure Causes NYHA Heart Failure Classification Diastolic Heart Failure Systolic Dysfunction Atrial Fibrillation Acute Management Atrial Fibrillation Anticoagulation Coronary Artery Disease Prevention in Diabetes Hypertension in Diabetes Mellitus CHAD Score Hypertension in the Elderly Isolated Systolic Hypertension Hypertension Criteria Hypertension Evaluation History Hypertension Management Hypertension Risk Stratification Resistant Hypertension Hypertension Management for Specific Comorbid Diseases Hypertension Management for Specific Emergencies Bacterial Endocarditis HDL Cholesterol LDL Cholesterol Triglyceride VLDL Cholesterol Hypercholesterolemia Hypertriglyceridemia AntiHyperlipidemic Hypertensive Disorders of Pregnancy Preeclampsia Prevention Congenital Heart Disease Hypertension in Children Medication Causes of Hypertension ACE Inhibitor Angiotensin 2 Receptor Blocking Agent Dihydropyridine Calcium Channel Blocker Nifedipine Selective Aldosterone Receptor Antagonist Niacin HMG-CoA Reductase Inhibitor Cardiac Risk Cardiac Risk Management Exercise Stress Test Stress Myocardial Perfusion Imaging Preoperative Cardiovascular Evaluation Eagle's Cardiac Risk Assessment Revised Cardiac Risk Index ACC-AHA Preoperative Cardiac Risk Assessment ACP Preoperative Cardiac Risk Assessment Syncope Subclavian Steal Syndrome Periodontitis Oral Health Cellulitis Necrotizing Soft Tissue Infection Group A Streptococcal Cellulitis Vibrio Cellulitis Gram-Negative Toe Web Infection Impetigo Skin Infections in Diabetes Mellitus Erythralgia Blister Skin Ulcer Cutaneous Candidiasis Onychomycosis Alopecia Areata Skin Abscess Skin Infection Intertrigo Nail Discoloration Terry's Nail Ingrown Toenail Hyperpigmentation Carotenemia Incision and Drainage Cryotherapy Skin Conditions in Diabetes Mellitus Acanthosis Nigricans Diabetic Dermopathy Granuloma Annulare Necrobiosis Lipoidica Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Metabolic Syndrome Diabetes Mellitus Complications Diabetic Ketoacidosis Diabetic Ketoacidosis Management in Adults Diabetic Ketoacidosis Management in Children Hyperosmolar Hyperglycemic State Diabetic Education Diabetes Mellitus Glucose Management Diabetes Mellitus Control in Hospital Diabetes Resources Diabetic Retinopathy Unintentional Weight Loss Unintentional Weight Loss Causes Hypoglycemia Serum Glucose Glucose Challenge Test Glucose Tolerance Test 2 hour Hemoglobin A1C Sex Hormone Binding Globulin Endocrinology Links Diabetic Neuropathy Neonatal Hypoglycemia Obesity Risk Gestational Diabetes Gestational Diabetes Management Gestational Diabetes Perinatal Mortality Diabetes Mellitus Preconception Counseling Obesity in Children Systemic Corticosteroid Medication Causes of Hyperglycemia GlucoWatch Biographer Symlin Inhaled Insulin Somogyi Phenomena Glucophage Human Growth Hormone Orlistat Diabetic Foot Care Nutrition in Diabetes Mellitus Type 2 Diabetic Nephropathy Klinefelter Syndrome Hypogonadotropic Hypogonadism Pubertal Delay Exercise in Diabetes Mellitus Perioperative Diabetes Management Obesity Surgery Night Sweats Acute Otitis Externa Bacterial Otitis Externa Necrotizing Otitis Externa Hearing Loss Sensorineural Hearing Loss Vocal Cord Paralysis Thrush Manual Cerumen Removal Sinus XRay Acute Suppurative Sialoadenitis Rhinosinusitis Tinnitus Burning Mouth Syndrome Taste Dysfunction Loss of Smell Dry Mouth Salivary Gland Enlargement Tongue Pain Dysequilibrium Atrophic Glossitis Animal Bite Infected Animal Bite Human Bite Heat Illness Risk Factors Burn Management Trauma in Pregnancy Bacterial Conjunctivitis Central Retinal Artery Occlusion Open Angle Glaucoma Cataract Ischemic Optic Neuritis Vitreous Hemorrhage Laser In-Situ Keratomileusis Floaters Light Flashes Acute Vision Loss Health Concerns in the Elderly Infections in Older Adults Medication Use in the Elderly Failure to Thrive in the Elderly Fall Prevention in the Elderly Irritable Bowel Syndrome Constipation Causes Chronic Diarrhea Traveler's Diarrhea Esophageal Dysmotility Gastroesophageal Reflux Hemochromatosis Pancreatic Cancer Hepatitis C Nonalcoholic Fatty Liver Serum Angiotensin Converting Enzyme Liver Function Test Abnormality Lactase Deficiency Acute Pancreatitis Chronic Pancreatitis Osmotic Laxative Hepatotoxic Medication Traveler's Diarrhea Prophylaxis Pruritus Ani Perirectal Abscess Gastroparesis Whipple Procedure Upper Gastrointestinal Bleeding Dyspepsia Causes Nausea Causes Contraception HAIR-AN Syndrome Polycystic Ovary Disease Menopause Endometrial Cancer Risk Factor Candida Vulvovaginitis Anovulatory Bleeding Oral Contraceptive Female Sexual Dysfunction Cancer Survivor Care Serum Protein Electrophoresis Perioperative Anticoagulation Cardiovascular Manifestations of HIV HIV Presentation Hepatitis in HIV HIV Related Neuropathy Stavudine Emerging Infection Methicillin Resistant Staphylococcus Aureus Fever of Unknown Origin Candidiasis Neutropenic Fever Hepatitis B Vaccine Influenza Vaccine Postherpetic Neuralgia Fluoroquinolone Third Generation Fluoroquinolone Sulfonamide Travel Preparation Travel Immunization Influenza Dengue Legionella Acute Exacerbation of Chronic Bronchitis Pneumonia in the Elderly Pneumonia Churg-Strauss Syndrome Tuberculin Skin Test Cystic Fibrosis Isoniazid Lung Transplantation in Cystic Fibrosis Active Tuberculosis Treatment Medical Literature Autonomic Dysfunction Bell's Palsy Facial Nerve Paralysis Causes Dementia Agitation in Dementia Ischemic Stroke Stroke Pathophysiology CVA Management Multiple Sclerosis Down Syndrome Cranial Nerve 3 Coma Exam Hemiplegia Giant Cell Arteritis Spinal Headache CSF Protein Altered Level of Consciousness Causes Guillain Barre Syndrome Restless Leg Syndrome Triptan Prevention of Ischemic Stroke Nerve Conduction Velocity Paresthesia Causes Peripheral Neuropathy Asymmetric Peripheral Neuropathy Peripheral Neuropathy Tremor Neonatal Distress Causes Newborn History Newborn Exam Neonatal Jaundice Causes Respiratory Distress Syndrome in the Newborn Late Pregnancy Loss Preterm Labor First Trimester Bleeding Fetal Macrosomia Hyperemesis Gravidarum Medications in Pregnancy Ritodrine Terbutaline Pregnancy Risk Assessment Probe-to-Bone Test Shoulder History Dupuytren's Disease Septic Bursitis Spinal Infection Osteomyelitis Causes Vertebral Osteomyelitis Patellar Tendinopathy Meralgia Paresthetica Frozen Shoulder Exertional Compartment Syndrome Hip Pain Low Back Pain Red Flag Carpal Tunnel Syndrome Adolescent Health Bullying Ephedrine Ginseng Myoinositol Nonsteroidal Anti-inflammatory Lab Markers of Malnutrition Nutrition Guidelines Glycemic Index Non-nutritive Sweetener Conenzyme Q10 Mortality Statistics Adult Health Maintenance Screening DOT Examination Family History Refugee Health Exam Automobile Safety Substance Abuse Evaluation Alcohol Detoxification in Ambulatory Setting Major Depression Major Depression Differential Diagnosis Anorexia Nervosa Antabuse Selective Serotonin Reuptake Inhibitor Antipsychotic Medication Clozapine Olanzapine Psychosis Insomnia Causes Renal Artery Stenosis Idiopathic Cyclic Edema Acute Kidney Injury Risk Chronic Renal Failure Acute Glomerulonephritis Nephrotic Syndrome Serum Osmolality Hypomagnesemia Drug Dosing in Chronic Kidney Disease Hyperkalemia due to Medications Hyperkalemia Causes Prevention of Kidney Disease Progression Intravenous Contrast Related Acute Renal Failure Osteoporosis Evaluation Antiphospholipid Antibody Syndrome Systemic Lupus Erythematosus Polymyositis Differential Diagnosis Septic Joint Gouty Arthritis Fibromyalgia Charcot's Joint Charcot Foot Complex Regional Pain Syndrome Osteoarthritis Methotrexate Joint Injection Rheumatoid Arthritis Fatigue Causes Impairment Evaluation Pre-participation History Exercise Exercise in the Elderly Walking Program Scuba Diving Procedural Sedation and Analgesia Peripheral Arterial Occlusive Disease Peripheral Vascular Disease Management Venous Insufficiency Wound Decubitus Ulcer Foot Wound Leg Ulcer Causes Wound Repair Fishhook Removal Ankle-Brachial Index Preoperative Examination Gallstone Acalculous Cholecystitis Cholecystectomy Small Bowel Obstruction Bowel Pseudoobstruction Abdominal Muscle Wall Pain Abdominal Wall Pain Causes Hydrocolloid Dressing Suture Material Surgical Antibiotic Prophylaxis Male Infertility Testicular Failure Bladder Cancer Urinary Tract Infection Recurrent Cystitis Acute Bacterial Prostatitis Acute Pyelonephritis Erectile Dysfunction Erectile Dysfunction Causes Erectile Dysfunction Management Urinary Incontinence Overflow Incontinence Urine pH Urine Specific Gravity Enuresis Proteinuria in Children Balanitis Peyronie's Disease Benign Prostatic Hyperplasia Vasectomy Counseling Proteinuria Causes Targeted Cancer Therapy Acute Paronychia Chronic Paronychia Urinary Retention Decreased Visual Acuity Gastrointestinal Manifestations of Diabetes Mellitus Shoulder Osteoarthritis Vitiligo Cardiomyopathy Heart Transplant Contraceptive Selection in Diabetes Mellitus Periodontal Bleeding Perioperative Antiplatelet Therapy Charlson Comorbidity Index Constipation Causes in the Elderly Chronic Osteomyelitis Abnormal Gait and Balance Causes in the Elderly Calcium Channel Blocker Overdose Diverticular Bleeding Framingham Cardiac Risk Scale Cardiac Risk in Diabetes Score Outpatient Bleeding Risk Index Four Year Prognostic Index Diabetes Screening ABCD2 Score Urine Microalbumin Hearing Loss in Older Adults Preoperative Guidelines for Medications Prior to Surgery Contrast-Induced Nephropathy Risk Score Hyperlipidemia in Diabetes Mellitus Diamond and Forrester Chest Pain Prediction Rule Coronary Risk Stratification of Chest Pain Diabetes Sick Day Management Urinary Tract Infection in Geriatric Patients Insulinlike Growth Factor 1 Avascular Necrosis of the Femoral Head Family Practice Notebook Updates 2014 Emergency Care in ESRD Medication Compliance Slit Lamp Sulfonamide Allergy Health Care of the Homeless CHADS2-VASc Score Tuberculosis Risk Factors for progression from Latent to Active Disease Family Practice Notebook Updates 2015 Wound Infection Asymptomatic Bacteriuria Toxic Shock Syndrome Tetanus ASA Physical Status Classification System Family Practice Notebook Updates 2016 Solid Organ Transplant Calcineurin Inhibitor Cardiac Pacemaker Infection DAPT Score Acute Maculopathy Medication Causes of Delirium in the Elderly Family Practice Notebook Updates 2017 Major Bleeding Risk With Anticoagulants Severe Asymptomatic Hypertension Chronic Wound Family Practice Notebook Updates Stable Coronary Artery Disease Nocturia Polyuria Hyperhidrosis Causes Pneumaturia Anemia in Older Adults Type 2 Diabetes Mellitus in Children

Regular ophthalmological examinations are recommended for early detection of diabetic retinopathy. The patient is educated about diabetes, its possible complications and their management, and the importance of adherence to the prescribed therapy. The patient is taught the importance of maintaining normal blood pressure levels (120/80 mm Hg or lower). Control of even mild-to-moderate hypertension results in fewer diabetic complications, esp. nephropathy, cerebrovascular disease, and cardiovascular disease. Limiting alcohol intake to approximately one drink daily and avoiding tobacco are also important for self-management. Emotional support and a realistic assessment of the patient's condition are offered; this assessment should stress that, with proper treatment, the patient can have a near-normal lifestyle and life expectancy. Long-term goals for a patient with diabetes should include achieving and maintaining optimal metabolic outcomes to prevent complications; modifying diet and lifestyle to prevent and treat obesity, dyslipidemia, cardiovascular disease, hypertension, and nephropathy; improving physical activity; and allowing for the patient’s nutritional and psychosocial needs and preferences. Assistance is offered to help the patient develop positive coping strategies. It is estimated that 23 million Americans will be diabetic by the year 2030. The increasing prevalence of obesity coincides with the increasing incidence of diabetes; approx. 45% of those diagnosed receive optimal care according to established guidelines. According to the CDC, the NIH, and the ADA, about 40% of Americans between ages 40 and 74 have prediabetes, putting them at increased risk for type 2 diabetes and cardiovascular disease. Lifestyle changes with a focus on decreasing obesity can prevent or delay the onset of diabetes in 58% of this population. The patient and family should be referred to local and national support and information groups and may require psychological counseling.
Patients with type 1 DM, unless they have had a pancreatic transplant, require insulin to live; intensive therapy with insulin to limit hyperglycemia (“tight control”) is more effective than conventional therapy in preventing the progression of serious microvascular complications such as kidney and retinal diseases. Intensive therapy consists of three or more doses of insulin injected or administered by infusion pump daily, with frequent self-monitoring of blood glucose levels as well as frequent changes in therapy as a result of contacts with health care professionals. Some negative aspects of intensive therapy include a three times more frequent occurrence of severe hypoglycemia, weight gain, and an adverse effect on serum lipid levels, i.e., a rise in total cholesterol, LDL cholesterol, and triglycerides and a fall in HDL cholesterol. Participation in an intensive therapy program requires a motivated patient, but it can dramatically reduce eye, nerve, and renal complications compared to conventional therapy. See: insulin pump for illus.
Lose Weight: If you are overweight, losing weight can help your body use insulin. In fact, the American Diabetes Association recommends that people with diabetes lose about 7 percent of their body weight, which should improve the way your body uses insulin and reduces insulin resistance. In addition, weight loss can help lower blood pressure, reduce joint pain, increase energy, and reduce sleep apnea and cholesterol. It can also reduce your risk of other diseases, including heart disease.
The diabetic patient should learn to recognize symptoms of low blood sugar (such as confusion, sweats, and palpitations) and high blood sugar (such as, polyuria and polydipsia). When either condition results in hospitalization, vital signs, weight, fluid intake, urine output, and caloric intake are accurately documented. Serum glucose and urine ketone levels are evaluated. Chronic management of DM is also based on periodic measurement of glycosylated hemoglobin levels (HbA1c). Elevated levels of HbA1c suggest poor long-term glucose control. The effects of diabetes on other body systems (such as cerebrovascular, coronary artery, and peripheral vascular) should be regularly assessed. Patients should be evaluated regularly for retinal disease and visual impairment and peripheral and autonomic nervous system abnormalities, e.g., loss of sensation in the feet. The patient is observed for signs and symptoms of diabetic neuropathy, e.g., numbness or pain in the hands and feet, decreased vibratory sense, footdrop, and neurogenic bladder. The urine is checked for microalbumin or overt protein losses, an early indication of nephropathy. The combination of peripheral neuropathy and peripheral arterial disease results in changes in the skin and microvasculature that lead to ulcer formation on the feet and lower legs with poor healing. Approx. 45,000 lower-extremity diabetic amputations are performed in the U.S. each year. Many amputees have a second amputation within five years. Most of these amputations are preventable with regular foot care and examinations. Diabetic patients and their providers should look for changes in sensation to touch and vibration, the integrity of pulses, capillary refill, and the skin. All injuries, cuts, and blisters should be treated promptly. The patient should avoid constricting hose, slippers, shoes, and bed linens or walking barefoot. The patient with ulcerated or insensitive feet is referred to a podiatrist for continuing foot care and is warned that decreased sensation can mask injuries.
Jump up ^ Boussageon, R; Supper, I; Bejan-Angoulvant, T; Kellou, N; Cucherat, M; Boissel, JP; Kassai, B; Moreau, A; Gueyffier, F; Cornu, C (2012). Groop, Leif, ed. "Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials". PLOS Medicine. 9 (4): e1001204. doi:10.1371/journal.pmed.1001204. PMC 3323508. PMID 22509138.
2. Home glucose monitoring using either a visually read test or a digital readout of the glucose concentration in a drop of blood. Patients can usually learn to use the necessary equipment and perform finger sticks. They keep a daily record of findings and are taught to adjust insulin dosage accordingly. More recent glucose monitoring devices can draw blood from other locations on the body, such as the forearm.

Skin care: High blood glucose and poor circulation can lead to skin problems such as slow healing after an injury or frequent infections. Make sure to wash every day with a mild soap and warm water, protect your skin by using sunscreen, take good care of any cuts or scrapes with proper cleansing and bandaging, and see your doctor when cuts heal slowly or if an infection develops.

Large, population-based studies in China, Finland and USA have recently demonstrated the feasibility of preventing, or delaying, the onset of diabetes in overweight subjects with mild glucose intolerance (IGT). The studies suggest that even moderate reduction in weight and only half an hour of walking each day reduced the incidence of diabetes by more than one half.
The causes of diabetes mellitus are unclear, however, there seem to be both hereditary (genetic factors passed on in families) and environmental factors involved. Research has shown that some people who develop diabetes have common genetic markers. In Type I diabetes, the immune system, the body's defense system against infection, is believed to be triggered by a virus or another microorganism that destroys cells in the pancreas that produce insulin. In Type II diabetes, age, obesity, and family history of diabetes play a role.
Diabetic retinopathy is a leading cause of blindness and visual disability. Diabetes mellitus is associated with damage to the small blood vessels in the retina, resulting in loss of vision. Findings, consistent from study to study, make it possible to suggest that, after 15 years of diabetes, approximately 2% of people become blind, while about 10% develop severe visual handicap. Loss of vision due to certain types of glaucoma and cataract may also be more common in people with diabetes than in those without the disease.

Regular insulin is fast-acting and starts to work within 15-30 minutes, with its peak glucose-lowering effect about two hours after it is injected. Its effects last for about four to six hours. NPH (neutral protamine Hagedorn) and Lente insulin are intermediate-acting, starting to work within one to three hours and lasting up to 18-26 hours. Ultra-lente is a long-acting form of insulin that starts to work within four to eight hours and lasts 28-36 hours.
Insulin treatment can cause weight gain and low blood sugar. In addition, there may be discomfort at the injection site. There are several types of tablets used to treat diabetes and they have different side-effects. The most common are diarrhoea (metformin), nausea (GLP-1 agoniists), weight-gain (sulphonylureas and pioglitazone), low blood sugar (sulphonylureas) and genital thrush (SGLT2 inhibitors). However, not all patients will experience some or any of these side-effects and patients should discuss any concerns with their doctor.
In ‘type 2 diabetes’ (previously called non-insulin-dependent diabetes mellitus), which accounts for 90% of all diabetes, the beta cells do not stop making insulin completely, but the insulin produced does not work properly so it struggles to store the sugar found in the blood. As a consequence, the pancreas has to produce more insulin to compensate for this reduction in insulin function. This is called insulin resistance and is commonly linked to obesity. This type of diabetes is seen more commonly over the age of 40 years but can occur at any age.  
Arlan L Rosenbloom, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Epidemiology, American Pediatric Society, Endocrine Society, Pediatric Endocrine Society, Society for Pediatric Research, Florida Chapter of The American Academy of Pediatrics, Florida Pediatric Society, International Society for Pediatric and Adolescent Diabetes
Some patients with type 2 DM can control their disease with a calorically restricted diet (for instance 1600 to 1800 cal/day), regular aerobic exercise, and weight loss. Most patients, however, require the addition of some form of oral hypoglycemic drug or insulin. Oral agents to control DM include sulfonylurea drugs (such as glipizide), which increase pancreatic secretion of insulin; biguanides or thiazolidinediones (such as metformin or pioglitazone), which increase cellular sensitivity to insulin; or a-glucosidase inhibitors (such as acarbose), which decrease the absorption of carbohydrates from the gastrointestinal tract. Both types of diabetics also may be prescribed pramlintide (Symlin), a synthetic analog of human amylin, a hormone manufactured in the pancreatic beta cells. It enhances postprandial glucose control by slowing gastric emptying, decreasing postprandial glucagon concentrations, and regulating appetite and food intake; thus pramlintide is helpful for patients who do not achieve optimal glucose control with insulin and/or oral antidiabetic agents. When combinations of these agents fail to normalize blood glucose levels, insulin injections are added. Tight glucose control can reduce the patient’s risk of many of the complications of the disease. See: illustration

You can develop type 2 diabetes at any age, even during childhood. However, type 2 diabetes occurs most often in middle-aged and older people. You are more likely to develop type 2 diabetes if you are age 45 or older, have a family history of diabetes, or are overweight or obese. Diabetes is more common in people who are African American, Hispanic/Latino, American Indian, Asian American, or Pacific Islander.


a complex disorder of carbohydrate, fat, and protein metabolism that is primarily a result of a deficiency or complete lack of insulin secretion by the beta cells of the pancreas or resistance to insulin. The disease is often familial but may be acquired, as in Cushing's syndrome, as a result of the administration of excessive glucocorticoid. The various forms of diabetes have been organized into categories developed by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus of the American Diabetes Association. Type 1 diabetes mellitus in this classification scheme includes patients with diabetes caused by an autoimmune process, dependent on insulin to prevent ketosis. This group was previously called type I, insulin-dependent diabetes mellitus, juvenile-onset diabetes, brittle diabetes, or ketosis-prone diabetes. Patients with type 2 diabetes mellitus are those previously designated as having type II, non-insulin-dependent diabetes mellitus, maturity-onset diabetes, adult-onset diabetes, ketosis-resistant diabetes, or stable diabetes. Those with gestational diabetes mellitus are women in whom glucose intolerance develops during pregnancy. Other types of diabetes are associated with a pancreatic disease, hormonal changes, adverse effects of drugs, or genetic or other anomalies. A fourth subclass, the impaired glucose tolerance group, also called prediabetes, includes persons whose blood glucose levels are abnormal although not sufficiently above the normal range to be diagnosed as having diabetes. Approximately 95% of the 18 million diabetes patients in the United States are classified as type 2, and more than 70% of those patients are obese. About 1.3 million new cases of diabetes mellitus are diagnosed in the United States each year. Contributing factors to the development of diabetes are heredity; obesity; sedentary life-style; high-fat, low-fiber diets; hypertension; and aging. See also impaired glucose tolerance, potential abnormality of glucose tolerance, previous abnormality of glucose tolerance.

Diabetic neuropathy is probably the most common complication of diabetes. Studies suggest that up to 50% of people with diabetes are affected to some degree. Major risk factors of this condition are the level and duration of elevated blood glucose. Neuropathy can lead to sensory loss and damage to the limbs. It is also a major cause of impotence in diabetic men.
If eaten as part of a healthy meal plan, or combined with exercise, sweets and desserts can be eaten by people with diabetes. They are no more "off limits" to people with diabetes than they are to people without diabetes. The key to sweets is to have a very small portion and save them for special occasions so you focus your meal on more healthful foods.

The definition of a genetic disease is a disorder or condition caused by abnormalities in a person's genome. Some types of genetic inheritance include single inheritance, including cystic fibrosis, sickle cell anemia, Marfan syndrome, and hemochromatosis. Other types of genetic diseases include multifactorial inheritance. Still other types of genetic diseases include chromosome abnormalities (for example, Turner syndrome, and Klinefelter syndrome), and mitochondrial inheritance (for example, epilepsy and dementia).
The word diabetes (/ˌdaɪ.əˈbiːtiːz/ or /ˌdaɪ.əˈbiːtɪs/) comes from Latin diabētēs, which in turn comes from Ancient Greek διαβήτης (diabētēs), which literally means "a passer through; a siphon".[111] Ancient Greek physician Aretaeus of Cappadocia (fl. 1st century CE) used that word, with the intended meaning "excessive discharge of urine", as the name for the disease.[112][113] Ultimately, the word comes from Greek διαβαίνειν (diabainein), meaning "to pass through,"[111] which is composed of δια- (dia-), meaning "through" and βαίνειν (bainein), meaning "to go".[112] The word "diabetes" is first recorded in English, in the form diabete, in a medical text written around 1425.
Diabetes mellitus (DM) is a strong predictor of cardiovascular morbidity and mortality and is associated with both micro- and macrovascular complications.1 Cardiovascular disease (CVD) causes up to 70% of all deaths in people with DM. The epidemic of DM will thus be followed by a burden of diabetes-related vascular diseases. The number of DM patients increases with aging of the population, in part because of the increasing prevalence of obesity and sedentary lifestyle. Although the mortality from coronary artery disease (CAD) in patients without DM has declined since the 1990s, the mortality in men with type 2 diabetes (T2DM) has not changed significantly.2 Moreover, DM is an independent risk factor for heart failure. Heart failure is closely related to diabetic cardiomyopathy: changes in the structure and function of the myocardium are not directly linked to CAD or hypertension. Diabetic cardiomyopathy is clinically characterized by an initial increase in left ventricular stiffness and subclinical diastolic dysfunction, gradually compromising left ventricular systolic function with loss of contractile function and progress into overt congestive heart failure. DM accounts for a significant percentage of patients with a diagnosis of heart failure in epidemiologic studies such as the Framingham Study and the UK Prospective Diabetes Study (UKPDS).2 A 1% increase in glycated hemoglobin (HbA1c) correlates to an increment of 8% in heart failure.3 The prevalence of heart failure in elderly diabetic patients is up to 30%.3
Type 2 diabetes can be prevented with lifestyle changes. People who are overweight and lose as little as 7 percent of their body weight and who increase physical activity (for example, walking 30 minutes per day) can decrease their risk of diabetes mellitus by more than 50%. Metformin and acarbose, drugs that are used to treat diabetes, may reduce the risk of diabetes in people with impaired glucose regulation.
In ‘type 2 diabetes’ (previously called non-insulin-dependent diabetes mellitus), which accounts for 90% of all diabetes, the beta cells do not stop making insulin completely, but the insulin produced does not work properly so it struggles to store the sugar found in the blood. As a consequence, the pancreas has to produce more insulin to compensate for this reduction in insulin function. This is called insulin resistance and is commonly linked to obesity. This type of diabetes is seen more commonly over the age of 40 years but can occur at any age.  
All you need to know about insulin sensitivity factor Insulin sensitivity factor is a measurement that describes how blood sugar levels are affected by taking 1 unit of insulin. It can help a person with type 1 diabetes regulate their blood sugar levels. Learn more about what insulin sensitivity factor is, who should test and when, and what the results mean. Read now
Jump up ^ O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW (January 2013). "2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 127 (4): e362–425. doi:10.1161/CIR.0b013e3182742cf6. PMID 23247304.
Insulin treatment can cause weight gain and low blood sugar. In addition, there may be discomfort at the injection site. There are several types of tablets used to treat diabetes and they have different side-effects. The most common are diarrhoea (metformin), nausea (GLP-1 agoniists), weight-gain (sulphonylureas and pioglitazone), low blood sugar (sulphonylureas) and genital thrush (SGLT2 inhibitors). However, not all patients will experience some or any of these side-effects and patients should discuss any concerns with their doctor.
Indigestion (dyspepsia) can be caused by diseases or conditions that involve the gastrointestinal (GI) tract, and also by some diseases and conditions that do not involve the GI tract. Indigestion can be a chronic condition in which the symptoms fluctuate infrequency and intensity. Signs and symptoms that accompany indigestion include pain in the chest, upper abdominal pain, belching, nausea, bloating, abdominal distention, feeling full after eating only a small portion of food, and rarely, vomiting.
×